Peter Donhauser reports a stock award at AVXL
By AlphaYouPublished Form 4
Donhauser Peter D.O.
Reporting filer
Peter D.O. Donhauser reports a stock award, not an open-market purchase or sale, in Anavex Life Sciences Corp.. Form 4 filed Nov 7, 2026 lists 1 entry.
- Disclosed
- Nov 7, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) (derivative) | Donhauser Peter D.O. | 2026-11-03 | A | Grant or award | 50000 | 0 | 50,000 | 4 days | Filed terms
|
Stock Option (Right to Buy) (derivative)
- Owner
- Donhauser Peter D.O.
- Date
- 2026-11-03
- Code
- A
- Action
- Grant or award
- Quantity
- 50000
- Price
- 0
- Following holdings
- 50,000
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Stock Option (Right to Buy)
- conversion Or Exercise Price: 1.20
- transaction Date: 2026-11-03
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 50000
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- id: F1
- expiration Date: 2036-11-02
- underlying Security Title: Common Stock
- underlying Security Shares: 50000
- shares Owned Following Transaction: 50000
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Donhauser Peter D.O.: Director.
- F1: The option vests in three substantially equal annual installments beginning on March 31, 2027
Original sources
Prepared automatically from public filing data. Report a correction.